Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)

NCT02709746 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02709746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2016
Completion date
July 30, 2019
Enrollment
784 (actual)
Sites
124

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major